about
Emerging importance of oxidative stress in regulating striated muscle elasticity.Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titinVagus nerve stimulation mitigates intrinsic cardiac neuronal remodeling and cardiac hypertrophy induced by chronic pressure overload in guinea pigPlatelet-Derived Growth Factor in Heart Failure.A multidimensional sight on cardiac failure: uncovered from structural to molecular level.Tampering with springs: phosphorylation of titin affecting the mechanical function of cardiomyocytes.Alternative Splicing of Titin Restores Diastolic Function in an HFpEF-Like Genetic Murine Model (TtnΔIAjxn)Measures of Ventricular-Arterial Coupling and Incident Heart Failure With Preserved Ejection Fraction: A Matched Case-Control Analysis.Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction.Protein phosphatase 5 regulates titin phosphorylation and function at a sarcomere-associated mechanosensor complex in cardiomyocytes.Pivotal role of α2 Na+ pumps and their high affinity ouabain binding site in cardiovascular health and disease.Management protocols for chronic heart failure in India.Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction.Heart Failure With Preserved Ejection Fraction: A Perioperative Review.Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose.Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction.
P2860
Q35155257-454B904C-C632-46F5-818F-BB6F95D5E1F5Q35328760-FF625923-691A-47FB-B5D5-464727B48304Q36975964-B46882ED-02CB-40F9-BF33-5E53DD4D2F1BQ38975525-0EDF8900-F138-49E7-9771-E8D3318DAE06Q39285223-777C4B4A-1EBE-43E5-BDFA-A09AC7E240B4Q39310690-2600089D-90D1-4286-8356-5757510AFC1EQ39547806-F4790B63-B5F0-4047-BD43-1AD11320F20AQ45063526-71E8D1B1-BFBE-4256-A748-DFD9D5EDC590Q47102600-FFB081A1-9D7A-4E67-80B8-01CBEF16776EQ48223158-8B0A6DDB-CB76-4E3B-87AA-5BD00BD35FF9Q48448938-E7907A14-C800-4C8D-B23D-6E233C53B829Q49887663-61B8870F-3DE2-4DDC-998D-A6381D0DF6E8Q50099011-4969B6AF-20A6-40DC-A906-B8045E6FB4E3Q50226285-492CEDE8-89BA-4EB2-A2EA-83200FBA8995Q52335223-54EE90F9-8A45-4C45-A507-ED6F216648BAQ55425790-8AE9DD81-F39B-43E0-800F-53E4B4ADFE2AQ55498546-34A3F414-9108-4818-A1DD-D6D463D5D627
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Heart failure with preserved ejection fraction
@ast
Heart failure with preserved ejection fraction
@en
Heart failure with preserved ejection fraction
@nl
type
label
Heart failure with preserved ejection fraction
@ast
Heart failure with preserved ejection fraction
@en
Heart failure with preserved ejection fraction
@nl
prefLabel
Heart failure with preserved ejection fraction
@ast
Heart failure with preserved ejection fraction
@en
Heart failure with preserved ejection fraction
@nl
P2093
P2860
P1433
P1476
Heart failure with preserved ejection fraction
@en
P2093
James D. Gladden
Margaret M. Redfield
Wolfgang A. Linke
P2860
P2888
P304
P356
10.1007/S00424-014-1480-8
P407
P577
2014-06-01T00:00:00Z
P6179
1048974298